Literature DB >> 31373905

Pleural Fluid Cytokine Levels at Baseline and Over Time are Associated With Time to IPC Removal: An Exploratory Study.

Horiana B Grosu1, Wei Lu2, David E Ost1, Macarena R Vial3, Mike Hernandez4, Natasha Ghosh1, Laila Noor1, Arain M Hasan1, Lara Bashoura1, Saadia Faiz1, Dave Balachandran1, Roberto Casal1, George Eapen1, Vickie Shannon1, Ajay Sheshadri1, Ximing Tang2, Najib Rahman5,6,7, Ignacio I Wistuba2.   

Abstract

BACKGROUND: The behavior of pleural fluid cytokine (PFCs) levels and their association with pleurodesis after indwelling pleural catheter (IPC) placement is unknown.
OBJECTIVE: A prospective exploratory study was conducted to obtain preliminary data on PFC levels after IPC placement.
METHODS: The PFC panel consisted of 4 cytokines [interleukin -8 (IL-8), vascular endothelial growth factor, total (but not activated) transforming growth factor betas, and basic fibroblast growth factor], measured across 5 time points (T0: insertion; T1: 24 to 48 h; T2: 72 to 96 h; T3: 1 wk; and T4: 2 wk). Profile plots were used to identify patterns of change of PFC levels. Correlation matrices for each PFC over time were computed, and area under the curve (AUC) categories were used to compare the cumulative incidence of IPC removal. Auto pleurodesis was defined as elective catheter removal because of decreased drainage within 90 days of insertion.
RESULTS: A total of 22 patients provided complete data. Except for IL-8, the majority of PFCs demonstrated strong positive correlations across measurement time points. Patients with high AUCs for IL-8, basic fibroblast growth factor, and vascular endothelial growth factor had a higher cumulative incidence of IPC removal by 90 days than did patients with low AUCs.
CONCLUSION: This is the first study to evaluate longitudinal changes of pleural cytokine levels with respect to the likelihood of IPC removal and provide early evidence that the cytokine profile may be associated with the outcome of pleurodesis induced by IPCs. However, this is an exploratory study and further studies are needed to assess if these findings can be validated in further studies.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31373905      PMCID: PMC7032700          DOI: 10.1097/LBR.0000000000000602

Source DB:  PubMed          Journal:  J Bronchology Interv Pulmonol        ISSN: 1948-8270


  32 in total

1.  Pleural fibrinolytic activity is decreased in inflammation as demonstrated in quinacrine pleurodesis treatment of malignant pleural effusion.

Authors:  V Agrenius; J Chmielewska; O Widström; M Blombäck
Journal:  Am Rev Respir Dis       Date:  1989-11

2.  Interleukin-8 and markers of neutrophil degranulation in pleural effusions.

Authors:  R M Segura; J Alegre; E Varela; R Marti; J M Suriñach; J Jufresa; L Armadans; C Pascual; T Fernández de Sevilla
Journal:  Am J Respir Crit Care Med       Date:  1998-05       Impact factor: 21.405

3.  A single intrapleural injection of transforming growth factor-beta(2) produces an excellent pleurodesis in rabbits.

Authors:  R W Light; D S Cheng; Y C Lee; J Rogers; J Davidson; K B Lane
Journal:  Am J Respir Crit Care Med       Date:  2000-07       Impact factor: 21.405

4.  IL-8 induces neutrophil chemotaxis predominantly via type I IL-8 receptors.

Authors:  M E Hammond; G R Lapointe; P H Feucht; S Hilt; C A Gallegos; C A Gordon; M A Giedlin; G Mullenbach; P Tekamp-Olson
Journal:  J Immunol       Date:  1995-08-01       Impact factor: 5.422

5.  Inhibition of mammalian target of rapamycin augments lipopolysaccharide-induced lung injury and apoptosis.

Authors:  Jill A Fielhaber; Scott F Carroll; Anders B Dydensborg; Mitra Shourian; Alexandra Triantafillopoulos; Sharon Harel; Sabah N Hussain; Maxime Bouchard; Salman T Qureshi; Arnold S Kristof
Journal:  J Immunol       Date:  2012-03-26       Impact factor: 5.422

Review 6.  Vascular endothelial growth factor: the key mediator in pleural effusion formation.

Authors:  Carolyn S Grove; Y C Gary Lee
Journal:  Curr Opin Pulm Med       Date:  2002-07       Impact factor: 3.155

7.  Interleukin-8 in inflammatory rheumatic diseases: synovial fluid levels, relation to rheumatoid factors, production by mononuclear cells, and effects of gold sodium thiomalate and methotrexate.

Authors:  M Seitz; B Dewald; M Ceska; N Gerber; M Baggiolini
Journal:  Rheumatol Int       Date:  1992       Impact factor: 2.631

8.  Cytokine-stimulated human mesothelial cells produce chemotactic activity for neutrophils including NAP-1/IL-8.

Authors:  R B Goodman; R G Wood; T R Martin; O Hanson-Painton; G T Kinasewitz
Journal:  J Immunol       Date:  1992-01-15       Impact factor: 5.422

9.  Single-center experience with 250 tunnelled pleural catheter insertions for malignant pleural effusion.

Authors:  Alain Tremblay; Gaëtane Michaud
Journal:  Chest       Date:  2006-02       Impact factor: 9.410

10.  Increased coagulation activity of the pleura after tube drainage and quinacrine instillation in malignant pleural effusion.

Authors:  V Agrenius; J Chmielewska; O Widström; M Blombäck
Journal:  Eur Respir J       Date:  1991-10       Impact factor: 16.671

View more
  1 in total

Review 1.  Inflammation of the Pleural Cavity: A Review on Pathogenesis, Diagnosis and Implications in Tumor Pathophysiology.

Authors:  Georgia Karpathiou; Michel Péoc'h; Anand Sundaralingam; Najib Rahman; Marios E Froudarakis
Journal:  Cancers (Basel)       Date:  2022-03-10       Impact factor: 6.639

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.